Marilena Vrana: Advancing Early Diagnosis and Access to Plasma Medicines for World PI Week 2026
Marilena Vrana, Vice President at the Plasma Protein Therapeutics Association (PPTA) Europe, shared a post on LinkedIn:
“World PI Week 2026 is here.
Working in the plasma community, I am continually inspired by the strength and resilience of the people living with Primary Immunodeficiency that I have met from around the world.
This week is an important opportunity to raise awareness, amplify patient voices, and highlight the critical importance of early diagnosis and access to care. I’m proud to stand alongside patients, advocates, and partners who are driving progress every day.
Together, we must continue working toward a future where all patients have access to the support and treatments they need, including life-saving plasma–derived medicines.”
Find more posts featuring Marilena Vrana on Hemostasis Today.
-
Jun 23, 2026, 23:30Shunsuke Iwano: PMDA Introduces Greater Flexibility for Pediatric Factor VIII and IX Development in Japan
-
Jun 23, 2026, 23:05Rounak Dubey: ISBT Academy Session on Agentic AI
-
Jun 23, 2026, 22:59Mohammed Maher Babiker: When ‘Low Platelets’ aren’t Really Low
-
Jun 23, 2026, 22:49Giovanni Merlino: Why Does Stress Hyperglycemia Worsen Stroke Outcomes?
-
Jun 23, 2026, 22:41Tareq Abadl: Coombs Test – The Key to Detecting Immune-Mediated Hemolysis
-
Jun 23, 2026, 22:32How WFH Impacted the Bleeding Disorders Community in 2025
-
Jun 23, 2026, 22:03Erin VanDyke: A Journey Through VTE Leadership and Healthcare Transformation
-
Jun 23, 2026, 21:19Ahmed Koriesh: Join Us for Future of Stroke Care 2026
-
Jun 23, 2026, 20:30Aladdin Mohammad: Baseline IgG as a Key Predictor of Hypogammaglobulinaemia in AAV